Barbara Ann Karmanos Cancer Institute
177
17
23
111
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
20.3%
36 terminated/withdrawn out of 177 trials
75.5%
-11.0% vs industry average
2%
4 trials in Phase 3/4
56%
62 of 111 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (177)
MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer
Role: collaborator
A Study of the TheraBionic P1 Device in Breast Cancer
Role: lead
TheraBionic P1 Device in Subjects With Advanced Hepatocellular Carcinoma
Role: lead
A Study of Dabrafenib and/or Trametinib in Patients With Relapsed and/or Refractory Multiple Myeloma
Role: collaborator
Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors
Role: lead
A(B)VD Followed by Nivolumab as Frontline Therapy for Higher Risk Patients With Classical Hodgkin Lymphoma (HL)
Role: collaborator
F-Tryptophan PET/CT in Human Cancers
Role: lead
Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65
Role: collaborator
Ask Questions About Clinical Trials
Role: lead
A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer
Role: lead
CPI-613 (Devimistat) in Combination With Chemoradiation in Patients With Pancreatic Adenocarcinoma
Role: collaborator
Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal Cancer
Role: lead
Metformin Combined With Chemotherapy and/or Immunotherapy in Solid Malignancies
Role: lead
C.A.P.A.B.L.E. (CrossFit® and Physical Activity: A Better Life Experience)
Role: lead
Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer
Role: lead
Cannabis, Neuroinflammation, and Suicidal Ideation: A Supplemental Brain Imaging Study
Role: collaborator
Selinexor Plus Combination Chemotherapy in Treating Patients With Advanced B Cell Non-Hodgkin Lymphoma
Role: lead
Polatuzumab Vedotin and Combination Chemotherapy for the Treatment of Previously Untreated Lymphoma
Role: lead
A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients.
Role: lead
Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors
Role: lead